Gresíková M, Rada B, Holý A
Acta Virol. 1982 Dec;26(6):521-3.
Peroral treatment with 9-(R, S)-(2,3-dihydroxypropyl) adenine did not protect mice infected with tick-borne encephalitis (TBE) viruses (strains Hypr and Ir13) when the drug was administered at the time or infection and/or up to day 2 after infection. The analogue inhibited the haemagglutination activity of the Skalica strain in vitro.
当在感染时和/或感染后2天内给予9-(R,S)-(2,3-二羟基丙基)腺嘌呤进行口服治疗时,并未保护感染蜱传脑炎(TBE)病毒(Hypr和Ir13株)的小鼠。该类似物在体外抑制了Skalica株的血凝活性。